Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Mass Screening × Gastrointestinal × Clear all

Status

Completed 8 Recruiting 3 Unknown 2 Withdrawn 1 Not yet recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Breast 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 92 Fluorouracil 81 Gemcitabine 69 Leucovorin 67 Capecitabine 64 pembrolizumab 61 Nivolumab 60 Bevacizumab 56 durvalumab 44 Magnetic Resonance Spectroscopy 44 Irinotecan 44 Specimen Handling 41 Radiotherapy 39 Cisplatin 38 Paclitaxel 37 atezolizumab 34 130-nm albumin-bound paclitaxel 34 Biopsy 31 Cetuximab 27 Carboplatin 26 Albumin-Bound Paclitaxel 26 Taxes 23 dehydroftorafur 20 Ipilimumab 18 Drug Therapy 18 tislelizumab 17 Radiation 16 Docetaxel 16 Surgical Procedures, Operative 15 trifluridine tipiracil drug combination 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06335966 2026-03-17

BEST-RPP

OHSU Knight Cancer Institute

Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡